Compounded GLP-1 runs $75 to $549 a month.

It depends which price you mean. On the lowest advertised sticker, Ivim lists semaglutide from about $75/mo on a 12-month plan and Mochi lists $99/mo — but both add a separate monthly membership. On the lowest flat all-in price with no membership, MaxLife's 12-month semaglutide plan at $135/mo is the lowest in our set. Verify current pricing on each provider's own site.

Many programs advertise a low medication price but bill a separate monthly membership ($75 to $135) or add a per-dose upcharge as your dose increases. True monthly cost adds those together. Flat all-in programs with no membership and no dose upcharge are usually the most predictable.

In our set, MaxLife, TrimRx, Eden, Henry Meds, Willow, Fella Health, and Emerge advertise no separate membership fee, though several use dose-tiered pricing that raises the cost as your dose increases. Mochi, Ivim, and Zealthy bill a separate monthly membership on top of the medication price. Verify current terms on each provider's own site.

No. Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. They're prepared by U.S.-licensed compounding pharmacies when a licensed provider determines treatment is appropriate. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®.

The picture changed after the FDA declared the semaglutide and tirzepatide shortages resolved in 2025, which ended the broad shortage-era compounding many programs had relied on. Compounding is now generally limited to a specific, documented clinical need that a licensed prescriber signs off on for an individual patient — such as a verified allergy to an inactive ingredient in the brand product — not routine cost savings or preference. The FDA also warned some telehealth marketers in 2025, and compounded versions remain not FDA-approved. This is general information, not legal or medical advice.

Insurance generally does not cover compounded GLP-1, so it's usually cash pay. If you have coverage, the brand can end up cheaper: eligible commercial-insurance patients may pay around $25/mo for Zepbound® or Mounjaro® through a manufacturer savings card, and a Medicare pilot starting July 2026 is set to give some beneficiaries roughly $50/mo for certain weight-loss drugs. Without coverage, brand list prices run high — often $500 to $1,000+ a month. Verify your own coverage before assuming.

The differences come mostly from pricing structure, not the molecule. Programs use separate monthly membership fees (commonly $75 to $135), per-dose upcharges that rise as you titrate up, discounts for prepaying a longer plan, and pricing that only appears after an intake quiz. To compare honestly, add any membership fee to the medication price and use your expected maintenance-dose figure rather than the lowest advertised starting price.

The lowest advertised price isn't always the lowest true cost once a membership or dose upcharge is added, so flat all-in pricing with no membership tends to be the most predictable. Because compounded semaglutide and tirzepatide are not FDA-approved, pharmacy transparency matters as much as price — favor programs that name their compounding pharmacy. For some people, a brand product with a manufacturer savings card may beat compounded. There are no guarantees, and individual results vary.

Cancellation and refund friction is one of the most common complaints about these programs. Watch for automatic renewals, prepaid multi-month plans that are often non-refundable once dispensed, and non-refundable intake or consult fees. Read the cancellation and refund terms in full before you enroll or prepay, so you know exactly what's recoverable if you stop.

Sometimes. Beyond the medication price, watch for a separate monthly membership, per-dose upcharges as you titrate up, lab fees, shipping charges, and non-refundable consultation fees. The most honest way to compare programs is your true monthly cost: medication plus any membership plus any dose upcharge, checked against your expected maintenance dose rather than the intro price.